Kaplan-Meier analysis suggested that prostate cancer patients with high UBASH3B expression level experienced a significantly shorter overall survival of 5-year than those with low UBASH3B levels (p = 0.042) (Figure 1D). The gene discussed is UBASH3B; the disease is prostate carcinoma.